Industry Growth Insights published a new data on “Insomnia Treatment Drugs Market”. The research report is titled “Insomnia Treatment Drugs Market research by Types (Prescription Sleep Aids, Over the Counter (OTC) Sleep Aids), By Applications (Hospital, Pharmacy, Others), By Players/Companies F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Insomnia Treatment Drugs Market Research Report
By Type
Prescription Sleep Aids, Over the Counter (OTC) Sleep Aids
By Application
Hospital, Pharmacy, Others
By Companies
F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Insomnia Treatment Drugs Market Report Segments:
The global Insomnia Treatment Drugs market is segmented on the basis of:
Types
Prescription Sleep Aids, Over the Counter (OTC) Sleep Aids
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F.Hoffman La-Roche AG
- Merck & Co. Inc.
- Mylan N.V.
- Pfizer, Inc.
- Pernix Therapeutics
- Sanofi S.A.
- Takeda Pharmaceutical Company Ltd.
- Sumitomo Dainippon Pharma Co., Ltd
- Teva Pharmaceutical Industries Ltd.
- Vanda Pharmaceuticals, Inc.
Highlights of The Insomnia Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Sleep Aids
- Over the Counter (OTC) Sleep Aids
- By Application:
- Hospital
- Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insomnia Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are many different types of insomnia treatment drugs, but the most common are prescription medications. These medications can help you fall asleep and stay asleep, which is important because untreated insomnia can lead to problems such as weight gain, depression, and anxiety.
Some of the major companies in the insomnia treatment drugs market are F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insomnia Treatment Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Insomnia Treatment Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Insomnia Treatment Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Insomnia Treatment Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Insomnia Treatment Drugs Market Size & Forecast, 2018-2028 4.5.1 Insomnia Treatment Drugs Market Size and Y-o-Y Growth 4.5.2 Insomnia Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Insomnia Treatment Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Insomnia Treatment Drugs Market Size Forecast by Type
5.2.1 Prescription Sleep Aids
5.2.2 Over the Counter (OTC) Sleep Aids
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Insomnia Treatment Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Insomnia Treatment Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insomnia Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insomnia Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Insomnia Treatment Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Insomnia Treatment Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Insomnia Treatment Drugs Market Size Forecast by Type
9.6.1 Prescription Sleep Aids
9.6.2 Over the Counter (OTC) Sleep Aids
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Insomnia Treatment Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Insomnia Treatment Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Insomnia Treatment Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Insomnia Treatment Drugs Market Size Forecast by Type
10.6.1 Prescription Sleep Aids
10.6.2 Over the Counter (OTC) Sleep Aids
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Insomnia Treatment Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Insomnia Treatment Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Insomnia Treatment Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Insomnia Treatment Drugs Market Size Forecast by Type
11.6.1 Prescription Sleep Aids
11.6.2 Over the Counter (OTC) Sleep Aids
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Insomnia Treatment Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Insomnia Treatment Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Insomnia Treatment Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Insomnia Treatment Drugs Market Size Forecast by Type
12.6.1 Prescription Sleep Aids
12.6.2 Over the Counter (OTC) Sleep Aids
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Insomnia Treatment Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Insomnia Treatment Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Insomnia Treatment Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Insomnia Treatment Drugs Market Size Forecast by Type
13.6.1 Prescription Sleep Aids
13.6.2 Over the Counter (OTC) Sleep Aids
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Insomnia Treatment Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insomnia Treatment Drugs Market: Competitive Dashboard
14.2 Global Insomnia Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F.Hoffman La-Roche AG
14.3.2 Merck & Co. Inc.
14.3.3 Mylan N.V.
14.3.4 Pfizer, Inc.
14.3.5 Pernix Therapeutics
14.3.6 Sanofi S.A.
14.3.7 Takeda Pharmaceutical Company Ltd.
14.3.8 Sumitomo Dainippon Pharma Co., Ltd
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.10 Vanda Pharmaceuticals, Inc.